EMBL and IBEC aim to contribute to the discussion on challenges and opportunities in the expanding field of engineered multicellular systems.
Recent breakthroughs in stem cell biology, organ-on-chip assays, 3-D bioprinting, and cell mechanobiology have revolutionized our ability to design and assemble multicellular living systems, from organoids to embryos.
This biennial series will focus on how engineering multicellular living systems is boosting our understanding of tissue and organ function, with applications in disease modelling, drug screening, and tissue engineering.
#EMBL_IBECConf
EARLY BIRD RATE Payment before/on 01/03 | 430€ |
LATE RATE Payment after 01/03 | 530€ |
VAT included
The registration fee covers attendance to all sessions, lunches and coffee/tea breaks during the conference and conference materials
For any queries about the conference, including opportunities for collaborations or sponsorship, please contact with: ibeccommunications@ibecbarcelona.eu
Or fill in the contact form below and we will be in contact with you shortly:
SPEAKERS
08:30 – 09:10 | Registration |
09:10 – 09:30 | Opening remarks |
Session 1 | Chair: James Sharpe |
09:30 – 10:00 | Human pluripotent stem cells come of age in modelling cardiovascular diseases and toxicity. Christine Mummery, Leiden University, Netherlands. |
10:00 – 10:30 | Modelling post-implantation human development to yolk sac blood emergence Mo Ebrahimkhani, University of Pittsburgh, USA |
10:30 – 10:45 | Short Talk: Size control of in vitro somites Maria Costanzo, European Molecular Biology Laboratory, Spain |
10:45 – 11:00 | Sponsor Talk: A leap forward in cytoprotection Christoph Hoefer, Thermo Fisher Scientific |
11:00 – 11:30 | Coffee Break |
Session 2 | Chair: Josep Samitier |
11:30 – 12:00 | Coordination of morphogenesis and cell state by mechanical forces. Sara Wickstrom, Max Planck Institute for Molecular Biomedicine, Germany. |
12:00 – 12:15 | Short Talk: Mechanics of Human and Mouse Embryo Implantation Amélie Godeau, Institute for Bioengineering of Catalonia (IBEC) |
12:15 – 12:45 | Mitochondrial reprogramming regulates stem cell fate in early development. Maneesha Inamdar, Institute for Stem Cell Science and Regenerative Medicine, India |
12:45 – 13:15 | Flash talks |
13:15 – 14:45 | Lunch and Poster session (odd numbers) |
Session 3 | Chair: Vikas Trivedi |
14:45 – 15:15 | Epithelial Folding Irreversibility is Controlled by Elastoplastic Transition via Mechanosensitive Actin Bracket Formation. Satoru Okuda, WPI Kanazawa University, Japan. |
15:15 – 15:30 | Short Talk: Artificial extracellular matrices based on 3D hybrid hydrogels for immune cell and organoid manufacture Judith Guasch, ICMAB-CSIC |
15:30 – 16:00 | Coffee break |
16:00 – 16:30 | Optimizing hiPSC-Derived Spinal Cord Models by Engineering Synthetic Extracellular Matrix Microenvironments. Zaida Álvarez, Institute for Bioengineering of Catalonia, Spain. |
16:30 – 16:45 | Short Talk: Nematically-guided morphogenesis Pau Guillamat, Institute for Bioengineering of Catalonia, Spain |
16:45 – 17:15 | Modeling the menstrual cycle using endometrial organoids Margherita Turco, Friedrich Miescher Institute for Biomedical Research |
Satellite Programe | |
17:30 – 17:45 | Video essay “HeLa et al.” Tess Marschner, Artist-in-Residence at Institute of Bioengineering of Catalonia (IBEC) |
Session 4 | Chair: Kristina Haase |
09:00 – 9:30 | Constructing and deconstructing the human nervous system to study development and disease Sergiu Pașca, WU Tsai Neurciences Institute · Standford University, USA |
9:30 – 10:00 | Architected hydrogels for Engineering Aligned Tissues. Marcy Zenobi-Wong, Swiss Federal Institute for Technology, Switzerland. |
10:00 – 10:15 | Short Talk: Replicating Dynamic Immune Responses within a Microfluidic Human Skin Equivalent Model Sarah Hindle, Blizard Institute, Queen Mary University of London |
10:15 – 10:45 | Automatic inference and design of spatial regulatory mechanisms Daniel Lobo, University of Maryland, USA |
10:45 – 11:15 | Coffee Break |
Session 5 | Chair: Miki Ebisuya |
11:15 – 11:45 | Organoids to model human disease. Hans Clevers, Utrecht University, Netherlands. |
11:45 – 12:00 | Short Talk: Harnessing the rhythmic biology of early kidney formation for synthetic morphogenesis Alex Hughes, Department of Bioengineering, University of Pennsylvania |
12:00 – 12:30 | Myogenic differentiation, bioprocess optimization, and tissue engineering in a Pacific salmon model: using cellular agriculture technologies for sustainable seafood production. Arye Elfenbein, Wildtype, USA |
12:30 – 13:15 | Flash talk |
13:15 – 13:20 | Group photo |
13:20 – 14:30 | Lunch and Poster session (even numbers) |
Session 6 | Chair: Núria Montserrat |
14:30 – 14:50 | Short Talk: Role of mechanotransduction in the control of interneurons migration in the cortex Míriam Javier Torrent, University of Liège, GIGA Neurosciences |
14:50 – 15:20 | Access and Affordability Paradigms for Advanced Biomedical Technologies. Ubaka Ogbogu, University of Alberta, Canada. |
15:20 – 15:50 | Building Organoids by learning signaling gradients Sharad Ramanathan, Harvard University, USA |
15:50 – 16:15 | Cofee break |
16:15 – 16:45 | Stem Cell Modeling of Human Embryonic Development. Berna Sozen, Yale University, USA. |
16:45 – 17:00 | Short Talk: SHAPE: Investigating innate immunity in real microgravity aboard the International Space Station using advanced human bone marrow organoids. Ryan Sarkar, BMLS, Goethe University Frankfurt a.M. |
17:00 – 17:30 | Approaches to engineering spatially organized multicellular systems. Jamie Davies, The University of Edinburgh, UK |
Session 7 | Chair: Xavier Trepat |
09:00 – 9:30 |
|
9:30 – 9:45 | Short Talk: |
9:45 – 10:15 | Programming intercellular communication to assemble engineered neuromuscular systems. |
10:15 – 11:15 | Coffee break and Poster session |
11:45 – 12:15 | Break to build: exploring the role of fracture during morphogenesis. |
12:15 – 12:30 | Short Talk: |
12:30 – 13:00 | Retinal Organoid Transplantation |
13:00 – 13:15 | Closing remarks and farewell |
Check the poster and flash and short presentation list:
The conference includes poster sessions and contributed oral presentations where you will have the opportunity to present your work and discuss it with your colleagues.
Abstract submission deadline: 21/01/2024
Notification of acceptance: 13/02/2024
Date: 25th April · 11 AM to 12.30 PM IMAB Project: Involving the Senior Community in Advances in Bioengineering for health and healthy aging. Within the framework of the EMBL conference, we want to bring research closer to the society. In this year’s edition, we want to involve citizens over 65 years of age so that they know, understand and give their opinion on the latest research in Engineering of Multicellular Systems. For this reason, we will carry out workshop for them within the IMAB project, funded by the FECYT, about Organ and Tissue Regeneration. From these workshops, we aim to collect information about the opinions of this age group about the latest scientific progress. All the opinions will be collected in a report with the aim that they are considered when designing new research projects. |
Date: 24th April · 5:30 PM to 5:45 PM The artwork “HeLa et al.” by Tess Marschner will be showcased throughout the conference. Participants will have the chance to engage with the artist, who will be available during the poster sessions of the conference. Following our goal of promoting transdisciplinary research, we participate in different projects in which we incorporate artistic vision into the creation and dissemination of scientific knowledge made at IBEC. We are delighted to offer an ongoing open call for artists, providing a unique opportunity to collaborate with our researchers and explore the intersection between art and science. Our actual artist-in-residence is Tess Marschner, who is a visual artist from Leipzig (Germany). In her mostly videographic and research-based works, she examines the ways in which scientific and theoretical knowledge shapes and shifts social relations. Her focus is on feminist, non-human and animal actors. The video essay “HeLa et al.” is a reflection on female and/or reproductive (parts of) bodies in techno-sciences: Henrietta Lacks’ eternal cell line, the cloned sheep Dolly, wombs, eggs and mice appear both as technical objects of the (scientific) economy as well as actors that confuse the concept of the human and the associated ethical implications. “HeLa et al.” was created during her Artistic Residency at IBEC 2023/24. |
Scientists at EMBL Barcelona explore how tissues and organs function and develop, in health and disease.
We combine a number of themes and approaches to achieve this:
Using these approaches, EMBL Barcelona studies a variety of multicellular questions:
The Institute for Bioengineering of Catalonia (IBEC) is a leading-edge multidisciplinary research centre based in Barcelona that conducts excellent research at the frontiers of basic and life sciences linked with engineering to generate new knowledge and applications that helps to enhance health and quality of life.
IBEC create wealth by putting together biophysics, cell engineering, nanomedicine, biomaterials, tissue engineering and the applications of information technology to health.
IBEC is a non-profit-making foundation set up in 2005 by the Departments of Health and Innovation, Universities and Enterprise of the Government of Catalonia, the University of Barcelona and the Technical University of Catalonia.
At IBEC, frontier research is combined with specific transfer targets to produce new applied technologies to be used in life and health sciences. We have the versatility to generate excellent research and, at the same time, work with clinicians and industry to develop new diagnostic or treatment systems. The model envisaged by IBEC is inspired by a creative, innovative new ecosystem based on interaction between research experts in different enabling technologies (nano-bio-info-cogno) to generate new knowledge and engineering solutions in health technology.
The knowledge that exists in IBEC is placed at the service of science and society to progress in three major research programmes: